MK801 influences L-DOPA-induced dopamine release in intact and hemi-parkinson rats

European Journal of Pharmacology

Volumn 407, Issue 3, 2000, Pages 281-291

  Jonkers, Nadine ^a   Sarre, Sophie ^a   Ebinger, Guy ^b   Michotte, Yvette ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b University Hospital   (Belgium)

Author keywords

6 Hydroxydopamine; Dizocilpine (MK801); Levodopa; Microdialysis

Indexed keywords

BENSERAZIDE PLUS LEVODOPA; DIZOCILPINE; OXIDOPAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; MALE; MEDIAL FOREBRAIN BUNDLE; MICRODIALYSIS; NONHUMAN; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

ADRENERGIC AGENTS; ANIMAL; ANTIPARKINSON AGENTS; CORPUS STRIATUM; DIZOCILPINE MALEATE; DOPAMINE; EXCITATORY AMINO ACID ANTAGONISTS; LEVODOPA; MALE; MEDIAL FOREBRAIN BUNDLE; OXIDOPAMINE; PARKINSONIAN DISORDERS; RATS; RATS, WISTAR; SUBSTANTIA NIGRA; SUPPORT, NON-U.S. GOV'T;

EID: 0034602505     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00753-6     Document Type: Article

References (46)

1. Effects of L-dopa on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats
2. The functional anatomy of basal ganglia disorders
3. Preservation of dopamine release in the denervated striatum
4. Differential regulation of dopamine release by N-methyl-D-aspartate receptors in rat striatum after partial and extreme lesions of the nigrostriatal pathway
5. 3H]kainate
6. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus
7. NMDA receptor antagonists increase the release of dopamine in the substantia nigra of reserpine-treated rats
8. Electrophysiology of dopamine-denervated striatal neurons. Implications for Parkinson's Disease
9. Neuromodulatory actions of dopamine in the neostriatum are dependent upon the excitatory amino acid receptor subtypes activated
10. Presynaptic adenosine A2 and N-methyl-D-aspartate receptors regulate dopamine synthesis in rat striatal synaptosomes
11. Evidence for N-methyl-D-aspartate and AMPA subtypes of the glutamate receptor on substantia nigra dopamine neurons: possible preferential role for N-methyl-D-aspartate receptors
12. Behavioral and neurochemical recovery from partial 6-hydroxydopamine lesions of the substantia nigra is blocked by daily treatment with glutamate receptor antagonists MK-801 and CPP
13. Excitatory amino acid receptor antagonists modify regional cerebral metabolic responses to levodopa in 6-hydroxydopamine-lesioned rats
14. Differential effects of NMDA and non-NMDA antagonists on the activity of aromatic L-amino acid decarboxylase activity in the nigrostriatal dopamine pathway of the rat
15. Dual effects of L-3,4-dihydroxyphenylalanine on aromatic L-amino acid decarboxylase, dopamine release and motor stimulation in the reserpine-treated rat: evidence that behavior is dopamine independent
16. Dizocilpine enhances striatal tyrosine hydroxylase and aromatic L-amino acid decarboxylase activity
17. Effect of trihexyphenidyl, a non-selective antimuscarinic drug, on decarboxylation of L-dopa in hemi-Parkinson rats
18. Reserpine pretreatment prevents increases in extracellular striatal dopamine following L-DOPA administration in rats with nigrostriatal denervation
19. Postsynaptic integration of glutamatergic and dopaminergic signals in the striatum
20. Analysis of the clinical problems in parkinsonism and the complications of long-term levodopa therapy
21. Bilateral regulation of glutamate tissue and extracellular levels in caudate-putamen by midbrain dopamine neurons
22. Tyrosine phosphorylation of NMDA receptor in rat striatum: effects of 6-OH-dopamine lesions
23. Time-dependent changes in striatal glutamate synapses following a 6-hydroxydopamine lesion
24. Role of high-affinity dopamine uptake and impulse activity in the appearance of extracellular dopamine in striatum after administration of exogenous L-DOPA: studies in intact and 6-hydroxydopamine-treated rats
25. Opposite effects of NMDA receptor blockade on dopaminergic D1- and D2-mediated behavior in the 6-hydroxydopamine model of turning: relationship with c-fos expression
26. Simultaneous microdialysis in striatum and substantia nigra suggests that the nigra is a major site of action of L-dihydroxyphenylalanine in the 'hemi-parkinson' rat
27. Evidence that L-DOPA-induced rotational behavior is dependent on both striatal and nigral mechanisms
28. Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats
29. Reciprocal interaction between glutamate and dopamine in the pars reticulata of the rat substantia nigra: a microdialysis study
30. Pharmacological study of the cortical-induced excitation of subthalamic nucleus neurons in the rat: evidence for amino acids as putative neurotransmitters
31. Localization of N-methyl-D-aspartate receptors in the rat striatum: effects of specific lesions on the [3H]3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid binding
32. Biotransformation of L-dopa in striatum and substantia nigra of rats with a unilateral, nigrostriatal lesion: a microdialysis study
33. Biotransformation of locally applied L-dopa in the corpus striatum of the hemi-parkinson rat studied with microdialysis
34. Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat
35. Extracellular striatal dopamine and glutamate after decortication and kainate receptor stimulation, as measured by microdialysis
36. Anti-parkinsonian actions of glutamate antagonists-alone and with L-DOPA: a review of evidence and suggestions for possible mechanisms
37. Stimulation of basal and l-DOPA-induced motor activity by glutamate antagonists in animal models of Parkinson's disease
38. Effect of 6-OHDA lesions on striatal mRNA levels encoding for glutamate receptor subunits
39. Dopaminergic denervation of striatum results in elevated expression of NR2A subunit
40. Systemic administration of NMDA and AMPA receptor antagonists reverses the neurochemical changes induced by nigrostriatal denervation in basal ganglia
41. L-3,4-dihydroxyphenylalanine-induced dopamine release in the striatum of intact and 6-hydroxydopamine-treated rats: differential effects of monoamine oxidase A and B inhibitors
42. Glutamate receptors in striatum and substantia nigra: effects of medial forebrain bundle lesions
43. 3H] glutamate binding in primate brain
44. Increased dopamine release from striata of rats after unilateral nigrostriatal bundle damage